Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02499172Terminated
Open-label trial of cholera vaccine (inactivated, oral) in cholera (4 arms), sponsored by Johns Hopkins Bloomberg School of Public Health. Primary endpoint: Adverse Pregnancy Outcome. Started Jun 2015; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02499172.